Drugs / Ng-monomethyl-L-arginine (drug)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00345150 | — | hypertensive disorder | Regional Hospital Holstebro | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ng-monomethyl-L-arginine (drug) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00345150 ↗ |
| Known as | L-NMMA | “The study investigates the effects of Ng-monomethyl-L-arginine (L-NMMA) on:” NCT00345150 ↗ |
| Action | Inhibit | “non selective nitric oxide inhibitor” NCT00345150 ↗ |